XML 59 R42.htm IDEA: XBRL DOCUMENT v3.21.1
Subsequent Events - Additional Information (Details) - Research Collaboration Agreement - CRISPR-Cas9
3 Months Ended
May 05, 2021
Mar. 31, 2021
Development and Regulatory Approval Milestones    
Subsequent Event [Line Items]    
Potential future payments   Totaling less than mid-twenty million dollars
Subsequent Event | NK Cell Products    
Subsequent Event [Line Items]    
Number of non-exclusive rights to gene editing targets 5